FinscoFinsco

Core Laboratories (US.CLB)

Capital Allocation Audit · Period: 2010 – 2026

$Open the interactive terminal to run `audit` and explore all dimensions.→

Key Metrics

US.CLB · YoY: 2026 H1 vs 2025 H1

MetricValueYoY
FCF Conversion9.5%↓
ROE1.9%↓
Cash Conversion227.9%↑
D/E Ratio0.61↑
Gross Margin14.4%↓
US.CLB (Core Laboratories) | YoY: 2026 H1 vs 2025 H1


Metric            Value  YoY
----------------------------
FCF Conversion     9.5%    ↓
ROE                1.9%    ↓
Cash Conversion  227.9%    ↑
D/E Ratio          0.61    ↑
Gross Margin      14.4%    ↓
Key Metrics
US.CLB (Core Laboratories) | YoY: 2026 H1 vs 2025 H1
Metric Value YoY
----------------------------
FCF Conversion 9.5% ↓
ROE 1.9% ↓
Cash Conversion 227.9% ↑
D/E Ratio 0.61 ↑
Gross Margin 14.4% ↓

Audit Dimensions

Capital FlowReturnsEarning QualityDebt DisciplineMoat

Unlimited Companies

AppleMicrosoftAlphabet-CAlphabet-AAmazonNVIDIAMeta PlatformsTeslaBerkshire Hathaway-BJPMorganVisaJohnson & JohnsonWalmartProcter & GambleExxon MobilUnitedHealthHome DepotMasterCardPfizerAbbVieCoca-ColaPepsiCoCostcoNetflixAdvanced Micro DevicesMicron TechnologySanDiskSalesforceDisneyNikeBoeingCaterpillarGoldman SachsAlibabaPDD HoldingsJD.comNIO IncLi AutoBaiduTaiwan SemiconductorASML HoldingEli Lilly and CoBroadcomCiscoOracleIntelAT&TVerizonMerck & CoTexas InstrumentsUnited Parcel ServiceRTX CorpLowe's Companies